MGMT and glioblastoma: Unfortunately, our group of seven patients who received Temozolomide (TMZ) was too small for similar conclusions or any statistical evaluation (only three patients were diagnosed with astrocytoma II and 4 with GBM, and received chemotherapy; all of them, excluding one, had the mutation in IDH1 and the methylated MGMT; data not shown).